SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is currently facing significant volatility as investors brace for the upcoming FDA Advisory Committee meeting to evaluate the clinical efficacy of its DMD therapy. The community is sharply divided, with bulls pointing to robust Phase 3 data and strong support from the patient advocacy community, while bears are citing regulatory skepticism, insider selling, and potential patent litigation as major headwinds.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending following an agreement to expand its use of quantum computing technology across AT&T's network operations, a move aimed at enhancing optimization and network efficiency. While the stock has seen volatility as part of a broader macro-driven unwind in high-beta tech, the community is actively debating the company's long-term enterprise traction and valuation against its upcoming quarterly earnings report.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently the subject of intense retail speculation and volatility as investors debate the impact of upcoming share lock-up expirations against the company's long-term aerospace and AI infrastructure ambitions. Community sentiment remains sharply divided between bulls focused on successful flight milestones and long-term tech integration, and skeptics who are concerned about excessive valuation and potential selling pressure from institutional insiders.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros shares are trending as investors weigh potential market competition following an AstraZeneca trial result while looking ahead to key milestones like CMS reimbursement updates and EMA re-examination. The community is actively debating the significance of recent Symphony prescription data and its impact on the company's valuation versus long-term growth prospects.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is attracting intense investor attention following new executive orders aimed at accelerating U.S. quantum technology leadership and security infrastructure. While the community is actively debating the stock's long-term potential versus concerns over high valuations and insider selling, traders are closely monitoring how these government-linked catalysts will impact near-term momentum.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing a significant surge in investor attention following the appointment of Michael Severino as its new CEO, a move the community views as a critical step toward restoring corporate credibility. Discussion is further amplified by market activity surrounding Capricor Therapeutics, with investors viewing the developments at both firms as potential catalysts for a bullish shift in sentiment as they head toward the next earnings update.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is trending as investors monitor the company's efforts to secure a third attempt at FDA approval for RP1, following an alignment with the agency on a resubmission path. The community remains sharply divided, with intense debate over the reliability of existing clinical data, the company's financial runway, and the potential impact of recent leadership shifts within the FDA.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending as it enters a definitive agreement to be acquired by Argenx in an all-cash transaction. The community is actively discussing the deal, with many noting the significant premium and the stock trading tightly aligned with the acquisition price as market participants treat the buyout as a finalized event.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is seeing increased investor attention as the company shifts toward a strategy of domestic supply chain resilience, highlighted by a new long-term memory and storage supply agreement with Micron. While the stock continues to navigate concerns regarding recall costs and broader automotive industry headwinds, community discussion remains focused on potential catalysts like upcoming EV platform developments and the potential for new energy sector contracts.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to a steep sell-off following the release of J&J's competitor data in the multiple myeloma space, which has triggered concerns about market share and future competitive pressure for the company's flagship therapy, Carvykti. Community discourse remains deeply divided, with some investors panic-selling due to the technical breakdown, while others aggressively accumulate shares, citing a massive disconnect between current price levels and the company's underlying fundamentals, cash position, and long-term M&A potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Freight Technologies Explores Sale Of Brokerage Unit

(RTTNews) - Freight Technologies Inc. (FRGT), a logistics company, on Thursday said it is accelerating its transition to a software-first, AI-driven business and is exploring strategic alternatives...

Algorhythm Holdings’ Stock Triples On AI Freight Tool Rollout: 3 Things Retail Investors Are Watching

Equity

Algorhythm said its SemiCab platform can help customers scale freight volumes by up to 400% without adding headcount, sparking a selloff across U.S. logistics stocks.   


AI Takes the Wheel: How Predictive Intelligence Is Reshaping Cross-Border Freight

As North American supply chains become increasingly digitized, the next competitive frontier is no longer just visibility; it's predictive intelligence. Shippers and brokers operating between the U.S. and Mexico face some of the most volatile pricing conditions in the logistics industry, driven by fluctuating fuel costs, border delays, security risks, and capacity swings. With AI adoption accelerating across the transportation sector, companies capable of forecasting rates and rapidly pairing loads with qualified carriers are emerging as the new power players in freight technology.Shares of Freight Technologies, Inc. (<a href="https://www.allpennystocks.com/stockquote/frgt" target="_blank">Nasdaq: FRGT</a>) are moving sharply higher Wednesday after the company announced the commercial launch of Zayren, its AI-powered freight-rate prediction and carrier-matching platform designed specifically for U.S.&#8211;Mexico cross-border and domestic over-the-road shipments.According to the company, Zayren was developed internally by Fr8Tech's Artificial Intelligence Lab and is built to analyze massive volumes of historical and real-time freight data. The platform provides instant pricing predictions for specific lanes, giving shippers and brokers a tool to benchmark rates, anticipate market movement, and react more efficiently to shifting demand. Users can input any origin&#8211;destination pair and receive immediate rate estimates generated by machine-learning models that continuously improve over time.A major component of the launch is Zayren's integrated AI agent, which automates the carrier-identification process. Instead of manually searching for available fleets, procurement teams receive curated lists of verified carriers complete with direct contact information, lane preferences, and operational details. The company noted that this reduces time-consuming back-and-forth communication and accelerates the matching process for both shippers and carriers.Zayren offers several access pathways during its initial rollout. Users of the company's Fleet Rocket transportation management system receive immediate exclusive access to the platform, integrating predictive pricing directly into their workflow. Shippers and brokers can also request demos and sign up for evaluation access, while carriers are being offered a 90-day free trial to join the Zayren network, upload preferred lanes, and connect with shippers at no cost during the trial period.CEO Javier Selgas said Zayren represents "a major step forward" in freight procurement for the U.S.&#8211;Mexico corridor, one of the most complex regions in North American logistics. He noted that combining the company's AI-driven pricing model with automated carrier matching provides unprecedented speed and transparency for operators who often struggle with rate volatility and limited capacity visibility.Umberto Le&#243;n Dom&#237;nguez, Director of the company's AI Lab, highlighted the platform's adaptability as a central advantage. Zayren gives companies the option to enhance the model with their own internal data, enabling more customized and accurate rate predictions over time. Dom&#237;nguez described the system as "a game changer in logistics automation" and emphasized that the commercial release is only the beginning of the company's broader AI expansion.The company also revealed that its AI Lab is developing voice-enabled AI agents expected to roll out in 2026. These next-generation tools aim to streamline additional logistics functions through conversational interfaces, pushing the company deeper into end-to-end automation across its technology ecosystem.Freight Technologies operates a growing suite of logistics solutions, including its flagship Fr8App platform for cross-border USMCA shipping, its Fr8Now LTL service, Fr8Fleet dedicated capacity offering, Waavely digital ocean freight tool, and Fleet Rocket, its transportation management system for brokers and shippers. All products sit within a unified technology environment designed to connect carriers and shippers more efficiently through AI, live pricing, real-time tracking, digital freight marketplaces, and committed capacity programs.Wednesday's announcement underscores the company's continued investment in AI-driven capabilities as it expands automation throughout the supply chain. With pricing volatility and capacity fragmentation presenting ongoing challenges in cross-border logistics, Zayren positions Freight Technologies to compete in one of the most strategically important freight markets in North America.Shares of FRGT are surging 56% to $1.03 in Wednesday morning trading. Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.View <a href='https://www.allpennystocks.com/specialreportsUS/4011/ai-takes-the-wheel-how-predictive-intelligence-is-reshaping-cross-border-freight'>more of this article</a> on AllPennyStocks.com.About AllPennyStocks.com Media, Inc.:
Founded in 1999, AllPennyStocks.com Media, Inc. is North America's largest and longest running website dedicated exclusively to micro-cap and small-cap insights.
Catering to both Canadian and U.S. markets, AllPennyStocks.com provides a wealth of resources and expert content designed for everyone, from beginner investors to seasoned traders.
AllPennyStocks.com's content is prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals.
Contact:
AllPennyStocks.com Media, Inc.
Email: <a href="mailto:ads@allpennystocks.com">ads@allpennystocks.com</a>
Phone: (800) 558-4560 Ext: 101

Freight Technologies Stock Rockets On Nestle Mexico Logistics Win: Retail Chatter Hits 9-Month High

The firm said that Nestle has entrusted Fr8App with the responsibility of supporting the seamless transportation of its products across Mexico.

Freight Technologies, Inc. engages in the development and operation of a cloud-based logistics management platform. It provides freight platforms for cross-border shipping. It offers the Fr8App for carriers, shippers, and all stakeholders in land-based logistics. The company was founded in 2015 and is headquartered in The Woodlands, TX.

Freight Technologies Inc

Bearish Sentiment

U.S. - Iran negotiations

Earnings

FOMC meeting

Other (drop a comment)

This week brings a Federal Reserve rate decision, Q2 GDP and PCE inflation data, and earnings from $MSFT, $META, $AAPL, and $AMZN. What will be the biggest driver of the market this week? Vote and explain your reasoning in the comments.

What will be the main driver of the market this week? 
 
Explain your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

FRGTFreight Technologies Inc

Latest Earnings Results:

Historical Earnings

Latest FRGT News